Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
The Middle East’s First Digital Asset Treasuries Summit Concludes in Abu Dhabi
-
All Trades Cover Unveils New Website to Better Serve Australia’s Tradie Community
-
Greenridge Exploration Announces Winter 2026 Drilling Program at the Hook-Carter Uranium Project in the Athabasca Basin, Saskatchewan in Partnership with Denison Mines
-
Alan Gould Joins Gray Media as Head of Investor Relations
-
CorMedix Therapeutics Announces Positive Data From Ongoing Real World Evidence Study of DefenCath
-
RESTEM to Participate in the 15th LifeSci Partners Corporate Access Event Held During the J.P. Morgan Healthcare Conference in January 2026
-
Asia Pacific Wire & Cable Corporation Limited Announces Commencement of Rights Offering
-
Catheter Precision (VTAK) Announces Expansion of LockeT into an Eighth European Country Since Receipt of CE Mark
-
Rezolve Ai Warns Generic LLM Chatbots Are Embarrassing Global Brands After The Gap, Inc. Incident
-
Genius Group Engages DLA Piper as Advisor on Australian Securities Exchange (ASX) Dual Listing.
-
Final, 247th participant randomized and commences treatment in Actinogen’s XanaMIA pivotal phase 2b/3 Alzheimer’s trial
-
Fusemachines Details Growth Strategy for 2026
-
GraniteShares Announces Weekly Distributions for its YieldBOOST ETFs: COYY, TSYY, NVYY, XBTY, AMYY, TQQY, AZYY, YSPY, MTYY, PLYY, HOYY, SMYY, BBYY, FBYY, IOYY, MAAY, NUGY, SEMY, QBY, RGYY, HMYY and RT
-
Edible Garden Begins Shipping Integrated Herb Program to Weis Markets
-
zSpace and Labtech Introduce Heavy Vehicle Fundamentals to Strengthen Diesel & Transportation Career Pathways with Immersive AR Learning
-
Ovid Therapeutics Reports Phase 1 Results for the First-Ever Direct Activator of Potassium-Chloride Cotransporter 2 (KCC2), OV350 Intravenous (IV)
-
OctoPaul Introduces OSpark.ai, a Free All-In-One AI Assistant That Merges Top Tools Into One Platform
-
America’s Car-Mart, Inc. Completes $161.3 Million Term Securitization
-
Valerie Mars Appointed to PureCycle’s Board of Directors
-
DIRTT Announces Renewal of Normal Course Issuer Bid for Common Shares
-
Nutriband Inc. Signs Letter of Intent with Qvanta Group of Companies to Explore Advanced Technology Solutions for Abuse-Deterrent Pharmaceutical Innovation Strategic Exploration
-
Meredith & The Media Appoints Former Adweek Editor David Cohen; Launches Friday Media Lunch Series With Coffee Communications
-
Custom Ink Selects Innovative Partnerships Group to Drive Growth in Sports, Entertainment, and University Industries
-
XWELL Expands Beyond Airports with New Wellness Retail Location in New York City’s Pennsylvania Station
-
Cocrystal Pharma Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus
-
LM Funding America Adds 35 PH/s with Energization of First Oklahoma Immersion Unit
-
CivicPlus Expands Accessibility and Special District Offerings with Streamline Acquisition
-
GlobalTech Corporation Closes Acquisition of Majority Stake of Moda in Pelle
-
BigCommerce Partners with Stripe to Support New Agentic Commerce Suite and Empower Merchants to Sell Through AI Agents While Maintaining Security
-
OFA Group Enters Beta Testing Phase for Hearth Labs’ Real-World Asset Launchpad Platform
-
HBT Financial, Inc. Announces Authorization of New $30 Million Stock Repurchase Program
-
Pacira Biosciences Joins PROBE Consortium to Transform Osteoarthritis Research and Care
-
Axalta Publishes 2023-2024 Sustainability Report
-
Icon Energy Corp. Announces Share Repurchase Program
-
Belgium’s Largest Fast-Charging Hub Opens in Mechelen
-
First Patient Dosed in SAB BIO’s SAFEGUARD Clinical Trial of SAB-142 for the Treatment of Stage 3 T1D
-
Alan Gould Joins Gray Media as Head of Investor Relations
-
WISeKey and OISTE Foundation Presented During the World Human Rights Concert at the United Nations Headquarters in Geneva
-
Stockwik acquires Labino
-
BitMEX Launches Year-End Gala: Win from a 3.5 BTC Prize Pool
-
Numab Therapeutics Achieves Milestone in Second Collaboration Project with Boehringer Ingelheim
-
Mobix Labs Reports Strong Fiscal 2025 Growth and Improved Operating Performance
-
CGTN: How China opens its door wider with island-wide special customs operations in Hainan FTP
-
Sezzle’s MoneyIQ Reaches One Million Lessons in Its First Year
-
Notification of major shareholding
-
Salarius Pharmaceuticals Announces Planned Corporate Name and Ticker Symbol Change to Decoy Therapeutics, Reflecting Strategic Pivot to Next-Generation Antiviral and Peptide-Conjugate Platform
-
Microbix Reports Results for Q4 and Fiscal 2025
-
McFarlane Commences Exploration Drilling at Juby Gold Project
-
Toobit Expands Futures Suite with 200x Leverage for ETHUSDT Perpetual Contracts
-
Appili Therapeutics Announces Closing of First Tranche of Non-Brokered Private Placement

